The effect of Montelukast on the prevention of nasal polyp recurrence

INTERVENTION: Intervention 1: Intervention group: The first intervention group: Group A received Montelukast tablets 10 mg daily, once at night for 6 weeks. Intervention 2: Intervention group: The second intervention group: group B receiving a topical steroid such as fluticasone 0.1 mg twice a day, 50 micrograms each time for 6 weeks. CONDITION: Chronic rhinosinusitis. ; Chronic rhinitis J31.0 PRIMARY OUTCOME: Cough. Timepoint: Runny nose before and 6 weeks after treatment. Method of measurement: By asking the patient. Decreased sense of smell Before and After Treatment. Timepoint: Runny nose before and 6 weeks after treatment. Method of measurement: By asking the patient. Headache. Timepoint: Runny nose before and 6 weeks after treatment. Method of measurement: By asking the patient. Nasal congestion. Timepoint: Runny nose before and 6 weeks after treatment. Method of measurement: By asking the patient. Pain around the eyes. Timepoint: Runny nose before and 6 weeks after treatment. Method of measurement: By asking the patient. Pus in the nose. Timepoint: Runny nose before and 6 weeks after treatment. Method of measurement: By asking the patient. Runny nose. Timepoint: Runny nose before and 6 weeks after treatment. Method of measurement: By asking the patient. Sinus pain. Timepoint: Runny nose before and 6 weeks after treatment. Method of measurement: By asking the patient. INCLUSION CRITERIA: Age over 18 years Candidate for endoscopic sinus surgery Consent to participate in the study Cooperation with the present research team